Massey Sally
SEC CIK 1815662 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CL | Colgate-Palmolive | CHRO | 15.4K | — | $9.53M | 35 | 2021-09-14 | 2026-09-16 |
Most active insiders at CL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wallace Noel R. | COB, Pres, CEO, Dir | — | $33.98M |
| 2 | SUTULA STANLEY J III | CFO | — | $9.22M |
| 3 | Tsourapas Panagiotis | COO, Eur, APac, Afr Eur, Skin | — | $5.70M |
| 4 | Massey Sally | CHRO | — | $2.36M |
| 5 | Daniels Jennifer | CLO, Sec | — | $2.08M |
| 6 | Hazlin John | Chief Growth Off | — | $1.98M |
| 7 | Malcolm Gregory | EVP, Ctrl | — | $1.41M |
| 8 | CAHILL JOHN T | Dir | — | $389.4K |
| 9 | Fishbone Betsy | CLO, Sec | — | — |
| 10 | GRANT SHANE | COO, Americas | — | — |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 16:09 | 2026-09-16 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +3,333 | 15.4K | +28% | $0 |
| M | 2026-09-15 16:10 | 2026-09-11+ | CL | Colgate-Palmolive | Massey Sally | CHRO | F - Tax | $86.80 | -1,796 | 12.1K | -13% | -$155.9K |
| 2026-05-11 16:05 | 2026-05-07 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $87.41 | -8,599 | 13.8K | -38% | -$751.6K | |
| 2026-02-25 | 2026-02-23 | CL | Colgate-Palmolive | Massey Sally | CHRO | F - Tax | $97.10 | -8,206 | 22.4K | -27% | -$796.8K | |
| 2026-02-25 | 2026-02-23 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +16.8K | 30.6K | +122% | $0 | |
| D | 2026-02-09 | 2026-02-05 | CL | Colgate-Palmolive | Massey Sally | CHRO | M - OptEx | $76.41 | +15.9K | 29.6K | +115% | +$1.21M |
| D | 2026-02-09 | 2026-02-05 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale+OE | $95.03 | -15.9K | 13.8K | -54% | -$1.51M |
| 2025-11-24 | 2025-11-21 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $80.89 | -1,237 | 13.8K | -8% | -$100.1K | |
| M | 2025-09-16 | 2025-09-12+ | CL | Colgate-Palmolive | Massey Sally | CHRO | F - Tax | $83.28 | -1,116 | 14.9K | -7% | -$92.9K |
| D | 2025-09-12 | 2025-09-11 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +3,450 | 16.1K | +27% | $0 |
| 2025-05-19 | 2025-05-15 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $88.97 | -2,250 | 12.6K | -15% | -$200.2K | |
| 2025-02-27 | 2025-02-25 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $92.02 | -8,000 | 14.8K | -35% | -$736.2K | |
| 2025-02-18 | 2025-02-13 | CL | Colgate-Palmolive | Massey Sally | CHRO | F - Tax | $87.75 | -5,057 | 22.8K | -18% | -$443.8K | |
| 2025-02-18 | 2025-02-13 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +12.1K | 27.8K | +77% | $0 | |
| D | 2024-09-16 | 2024-09-12 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +2,370 | 16.3K | +17% | $0 |
| D | 2024-09-16 | 2024-09-13 | CL | Colgate-Palmolive | Massey Sally | CHRO | F - Tax | $105.73 | -652 | 15.7K | -4% | -$68.9K |
| D | 2024-08-08 | 2024-08-06 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale+OE | $103.28 | -15.8K | 13.9K | -53% | -$1.64M |
| D | 2024-08-08 | 2024-08-06 | CL | Colgate-Palmolive | Massey Sally | CHRO | M - OptEx | $76.41 | +15.8K | 29.8K | +114% | +$1.21M |
| D | 2024-05-10 | 2024-05-09 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale+OE | $94.06 | -12.2K | 13.9K | -47% | -$1.15M |
| D | 2024-05-10 | 2024-05-09 | CL | Colgate-Palmolive | Massey Sally | CHRO | M - OptEx | $72.29 | +12.2K | 26.1K | +88% | +$883.8K |
| D | 2024-05-03 | 2024-05-01 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale+OE | $91.92 | -6,115 | 13.9K | -31% | -$562.1K |
| D | 2024-05-03 | 2024-05-01 | CL | Colgate-Palmolive | Massey Sally | CHRO | M - OptEx | $72.29 | +6,115 | 20.0K | +44% | +$442.1K |
| 2024-02-20 | 2024-02-15 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +5,468 | 17.7K | +45% | $0 | |
| M | 2024-02-20 | 2024-02-15+ | CL | Colgate-Palmolive | Massey Sally | CHRO | F - Tax | $83.53 | -3,751 | 15.4K | -20% | -$313.3K |
| D | 2023-09-15 | 2023-09-13 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +3,461 | 12.1K | +40% | $0 |
| D | 2023-05-17 | 2023-05-15 | CL | Colgate-Palmolive | Massey Sally | CHRO | M - OptEx | $73.00 | +14.6K | 23.2K | +169% | +$1.07M |
| D | 2023-05-17 | 2023-05-15 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale+OE | $81.55 | -14.6K | 8,615 | -63% | -$1.19M |
| D | 2023-05-05 | 2023-05-04 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale+OE | $81.16 | -17.2K | 8,615 | -67% | -$1.40M |
| D | 2023-05-05 | 2023-05-04 | CL | Colgate-Palmolive | Massey Sally | CHRO | M - OptEx | $68.16 | +17.2K | 25.9K | +200% | +$1.18M |
| 2023-02-21 | 2023-02-16 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +1,666 | 9,624 | +21% | $0 | |
| 2023-02-21 | 2023-02-17 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $73.25 | -1,009 | 8,615 | -10% | -$73.9K | |
| 2022-09-15 | 2022-09-13 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $77.58 | -656 | 7,913 | -8% | -$50.9K | |
| 2022-02-22 | 2022-02-17 | CL | Colgate-Palmolive | Massey Sally | CHRO | A - Grant | $0.00 | +2,764 | 10.1K | +37% | $0 | |
| 2022-02-22 | 2022-02-18 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $79.17 | -1,624 | 8,514 | -16% | -$128.6K | |
| 2021-09-15 | 2021-09-14 | CL | Colgate-Palmolive | Massey Sally | CHRO | S - Sale | $77.18 | -610 | 7,321 | -8% | -$47.1K |
Purchase Sale Sale after option exercise All abbreviations